The diagnostic criteria for suspected scrub typhus cases (meet criteria 1 and 2.1, and meet 1 of criteria 2.2 and 2.3), clinical scrub typhus cases (meet the diagnostic criterion of suspected scrub typhus and meet criterion 2.4; or meet criteria 1, 2.1, and 2.4), and confirmed scrub typhus cases (meet the diagnostic criterion of suspected scrub typhus and meet 1 of the criteria of 3.2, 3.3, and 3.4; meet the diagnostic criterion of clinical scrub typhus and meet 1 of criteria 3) were identified according to the guidebook for prevention and control of scrub typhus issued by the China CDC (Chinese Center for Disease Control and Prevention, 2009 ). One field exposure history: A person who had a field exposure history of being in a scrub typhus-endemic area 3 weeks before the onset of illness during the scrub typhus transmission season: 2 Clinical manifestations. 2.1 A person who had clinical manifestations of high fever; 2.2 A person who had clinical manifestations of lymphadenopathy; 2.3 A person who had clinical manifestations of skin rash; 2.4 A person who had clinical manifestations of typical cutaneous lesions (eschars or ulcers); 3 Laboratory tests: 3.1 Weil-Felix OX-K agglutination titer ≥ 1:160; 3.2 A 4-fold or greater rise in serum IgG antibody titers between acute and convalescent sera as detected by indirect immune fluorescence antibody assay (IFA); 3.3 Positive results of O. tsutsugamushi in clinical specimens by polymerase chain reaction (PCR); 3.4 Isolation of O. tsutsugamushi from clinical specimens.
Scrub Typhus Surveillance in China
The diagnostic criteria for suspected scrub typhus cases (meet criteria 1 and 2.1, and meet 1 of criteria 2.2 and 2.3), clinical scrub typhus cases (meet the diagnostic criterion of suspected scrub typhus and meet criterion 2.4; or meet criteria 1, 2.1, and 2.4), and confirmed scrub typhus cases (meet the diagnostic criterion of suspected scrub typhus and meet 1 of the criteria of 3.2, 3.3, and 3.4; meet the diagnostic criterion of clinical scrub typhus and meet 1 of criteria 3) were identified according to the guidebook for prevention and control of scrub typhus issued by the China CDC (Chinese Center for Disease Control and Prevention, 2009 ). One field exposure history: A person who had a field exposure history of being in a scrub typhus-endemic area 3 weeks before the onset of illness during the scrub typhus transmission season: 2 Clinical manifestations. 2.1 A person who had clinical manifestations of high fever; 2.2 A person who had clinical manifestations of lymphadenopathy; 2.3 A person who had clinical manifestations of skin rash; 2.4 A person who had clinical manifestations of typical cutaneous lesions (eschars or ulcers); 3 Laboratory tests: 3.1 Weil-Felix OX-K agglutination titer ≥ 1:160; 3.2 A 4-fold or greater rise in serum IgG antibody titers between acute and convalescent sera as detected by indirect immune fluorescence antibody assay (IFA); 3.3 Positive results of O. tsutsugamushi in clinical specimens by polymerase chain reaction (PCR); 3.4 Isolation of O. tsutsugamushi from clinical specimens.
Corresponding Organization :
Other organizations : National Institute for Communicable Disease Control and Prevention, China Meteorological Administration, Queensland University of Technology, Anhui Medical University, Shanghai Children's Medical Center, Shanghai Jiao Tong University, Nanjing Medical University
Variable analysis
- Not explicitly mentioned
- Weekly typhus cases from 59 prefecture-level administrative regions in 10 provinces in mainland China from January 1, 2006, to December 31, 2020
- Not explicitly mentioned
- Positive control: Weil-Felix OX-K agglutination titer ≥ 1:160
- Positive control: A 4-fold or greater rise in serum IgG antibody titers between acute and convalescent sera as detected by indirect immune fluorescence antibody assay (IFA)
- Positive control: Positive results of O. tsutsugamushi in clinical specimens by polymerase chain reaction (PCR)
- Positive control: Isolation of O. tsutsugamushi from clinical specimens
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!